Suppr超能文献

一项关于基于MRI与基于CT的子宫颈高剂量率近距离放射治疗的医疗保险成本分析:基于MRI的治疗计划成本会更低吗?

A Medicare cost analysis of MRI- versus CT-based high-dose-rate brachytherapy of the cervix: Can MRI-based planning be less costly?

作者信息

Bajaj Amishi, Harmon Grant, Weaver John, Martin Brendan, Mysz Michael, Surucu Murat, Roeske John C, Konski Andre A, Small William, Harkenrider Matthew M

机构信息

Department of Radiation Oncology, Stritch School of Medicine, Loyola University Chicago, Chicago, IL.

Clinical Research Office, Loyola University Chicago, Chicago, IL.

出版信息

Brachytherapy. 2018 Mar-Apr;17(2):326-333. doi: 10.1016/j.brachy.2017.11.020. Epub 2018 Jan 10.

Abstract

PURPOSE

While some institutions deliver multiple fractions per implant for MRI-based planning, it is common for only one fraction to be delivered per implant with CT-based cervical brachytherapy. The purpose of this study was to compare physician costs, hospital costs, and overall costs for cervical cancer patients treated with either CT-based or MRI-based high-dose-rate (HDR) cervical brachytherapy to determine if MRI-based brachytherapy as described can be financially feasible.

METHODS AND MATERIALS

We identified 40 consecutive patients treated with curative intent cervical brachytherapy. Twenty patients underwent CT-based HDR brachytherapy with five fractions delivered in five implants on nonconsecutive days in an outpatient setting with the first implant placed with a Smit sleeve under general anesthesia. Twenty patients received MRI-based HDR brachytherapy with four fractions delivered in two implants, each with MRI-based planning, performed 1-2 weeks apart with an overnight hospital admission for each implant. We used Medicare reimbursements to assess physician costs, hospital costs, and overall cost.

RESULTS

The median cost of MRI-based brachytherapy was $14,248.75 (interquartile range [IQR]: $13,421.32-$15,539.74), making it less costly than CT-based brachytherapy with conscious sedation (i.e., $18,278.85; IQR: $17,323.13-$19,863.03, p < 0.0001) and CT-based brachytherapy with deep sedation induced by an anesthesiologist (i.e., $27,673.44; IQR: $26,935.14-$29,511.16, p < 0.0001). CT-based brachytherapy with conscious sedation was more costly than CT-based brachytherapy with deep sedation (p < 0.001).

CONCLUSIONS

MRI-based brachytherapy using the described treatment course was less costly than both methods of CT-based brachytherapy. Cost does not need to be a barrier for MRI-based cervical brachytherapy, especially when delivering multiple fractions with the same application.

摘要

目的

虽然一些机构在基于磁共振成像(MRI)的计划中每个植入物给予多个分次,但在基于计算机断层扫描(CT)的宫颈癌近距离治疗中通常每个植入物仅给予一个分次。本研究的目的是比较接受基于CT或基于MRI的高剂量率(HDR)宫颈癌近距离治疗的患者的医生成本、医院成本和总成本,以确定所描述的基于MRI的近距离治疗在经济上是否可行。

方法和材料

我们确定了40例接受根治性宫颈癌近距离治疗的连续患者。20例患者接受基于CT的HDR近距离治疗,在门诊非连续日期分五次植入给予五个分次,首次植入在全身麻醉下使用斯密特套管进行。20例患者接受基于MRI的HDR近距离治疗,分两次植入给予四个分次,每次植入均基于MRI进行计划,两次植入间隔1 - 2周,每次植入均需住院过夜。我们使用医疗保险报销来评估医生成本、医院成本和总成本。

结果

基于MRI的近距离治疗的中位成本为14,248.75美元(四分位间距[IQR]:13,421.32 - 15,539.74美元),使其成本低于采用清醒镇静的基于CT的近距离治疗(即18,278.85美元;IQR:17,323.13 - 19,863.03美元,p < 0.0001)以及由麻醉医生诱导深度镇静的基于CT的近距离治疗(即27,673.44美元;IQR:26,935.14 - 29,511.16美元,p < 0.0001)。采用清醒镇静的基于CT的近距离治疗比采用深度镇静的基于CT的近距离治疗成本更高(p < 0.001)。

结论

采用所描述治疗方案的基于MRI的近距离治疗比两种基于CT的近距离治疗方法成本更低。成本不应成为基于MRI的宫颈癌近距离治疗的障碍,特别是在相同应用中给予多个分次时。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验